AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb

The companies have discussed a potential merger over several months, the Financial Times reported on Sunday.

By CNBC · CNBC

The companies have discussed a potential merger over several months, the Financial Times reported on Sunday.